Leica Microsystems has signed an agreement with
the Max Planck Society and the German Cancer Research Center (DKFZ) for the
development of the next generation of super-resolution STED (Stimulated
Emission Depletion) microscopy. This gives Leica Microsystems the license to
develop the new technology, called gated STED, into a commercial product and
put it on the market.
Professor
Stefan Hell, Director at the Max Planck Institute for Biophysical Chemistry,
has taken his idea of STED microscopy a momentous step further with gated STED:
The new technology significantly improves the resolution and contrast
previously attained with CW-STED (Continuous-Wave Stimulated Emission
Depletion) microscopy, while distinctly reducing laser intensity. This enhances
photostability as well as live cell capability, substantially extending the
range of possible applications. Also,
gated STED technology will considerably increase the number of questions that
can be addressed with STED fluorescence correlation spectroscopy (STED-FCS). The main
application of gated STED FCS will be the observation of molecule movements in
the membrane of living cells.
The new product of Leica Microsystems will be launched
in the first half of the year 2012. Thanks to Leica Microsystems' modular
concept, the Leica TCS SP5 and Leica TCS STED CW confocal systems already on
the market can be upgraded with gated STED.
"We're delighted to be able to continue the provenly
successful cooperation with the Max Planck Society, its technology transfer
organization Max Planck Innovation and the DKFZ with this trailblazing product
development," says Dr. Stefan Traeger, Vice President of Leica Microsystems'
Life Science Division. "The new gated STED microscope will enable us to further
strengthen our technological lead in super-resolution microscopy especially for
confocal systems. "
For further information visit
www.leica-microsystems.com
Leica Microsystems is
a world leader in microscopes and scientific instruments. Founded as a family
business in the nineteenth century, the company's history was marked by
unparalleled innovation on its way to becoming a global enterprise.
Its historically
close cooperation with the scientific community is the key to Leica
Microsystems' tradition of innovation, which draws on users' ideas and creates
solutions tailored to their requirements. At the global level, Leica
Microsystems is organized in four divisions, all of which are among the leaders
in their respective fields: the Life Science Division, Industry Division,
Biosystems Division and Medical Division.
Leica Microsystems'
Biosystems Division, also known as Leica Biosystems, offers histopathology
laboratories the most extensive product range with appropriate products for
each work step in histology and for a high level of productivity in the working
processes of the entire laboratory.
The company is represented
in over 100 countries with 12 manufacturing facilities in 7 countries, sales
and service organizations in 19 countries and an international network of
dealers. The company is headquartered in Wetzlar, Germany.
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.